Atlas Trials

Fingerprint Characterization Tyrosine Kinase Inhibitors in Advanced HCC

Clinical trial NCT03958669 · TERMINATED

Trial details

NCT number
NCT03958669
Sponsor
University Hospital Tuebingen
Status
TERMINATED
Study type
OBSERVATIONAL
Hepatocellular CarcinomaSorafenib
Start date
2019-11-01
Primary completion
2022-12-31
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.